Similarly, in mice transplanted with colorectal cancer cells, the combination of an anti-LAG-3 antibody plus an anti-PD-1 antibody revealed an enhanced control of the tumor growth as compared with the single treatments alone [203]. Here, LAG3 is linked to neoplasm.